Treatment Rationale and Study Design for the RELAY Study: A Multicenter, Randomized, Double-Blind Study of Erlotinib With Ramucirumab or Placebo in Patients With Epidermal Growth Factor Receptor Mutation-Positive Metastatic Non–Small-Cell Lung Cancer

  1. Garon, E.B.
  2. Reck, M.
  3. Paz-Ares, L.
  4. Ponce, S.
  5. Jaime, J.C.
  6. Juan, O.
  7. Nadal, E.
  8. Lee, P.
  9. Dalal, R.
  10. Liu, J.
  11. He, S.
  12. Treat, J.
  13. Nakagawa, K.
Zeitschrift:
Clinical Lung Cancer

ISSN: 1938-0690 1525-7304

Datum der Publikation: 2017

Ausgabe: 18

Nummer: 1

Seiten: 96-99

Art: Artikel

DOI: 10.1016/J.CLLC.2016.05.023 GOOGLE SCHOLAR